醫院感染檢測市場：依檢測類型和地區分類

Hospital-Acquired Disease Testing Market, By Test Type, By Geography

出版日期: 2026年04月06日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年醫院感染檢測市場規模估計為186億美元，預計2033年將達到494億美元。預計2026年至2033年，該市場將以15.5%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	186億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	15.50%	2033年市場規模預測：	494億美元

院內感染（HAC）是指病患在接受醫療服務期間所發生的感染。最常見的HAC類型包括尿道感染、血流感染疾病、抗藥性金黃色葡萄球菌（MRSA）感染、肺炎鏈球菌感染和胃腸道疾病。全球HAC發生率的不斷上升是傳染病檢查市場的主要促進因素。現代醫療機構使用的醫療設備，例如導尿管和人工呼吸器，也是這些感染疾病的重要來源。

市場動態

市場領導者正致力於透過併購、聯盟和夥伴關係等擴大策略，拓展產品系列，並擴大其在醫院傳染病檢查市場的全球影響力。例如，2019年4月，Meridian Bioscience公司達成協議，收購總部位於加拿大的分子診斷儀器和檢測產品供應商GenePOC公司。此次收購將把GenePOC公司先進的revogene分子診斷平台整合到Meridian Bioscience公司的診斷產品組合中。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數分析了全球醫院感染檢測市場的主要參與者：公司概況、財務績效、產品系列、市場佔有率、分銷策略、關鍵發展、策略和未來計劃。
透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
這份全球醫院感染檢測市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
相關人員可以透過利用全球醫院感染檢測市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第6章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Luminex Corporation
- Diatherix Laboratories
- Life Technologies
- Cantel Medical Corporation
- Meridian Biosciences Inc
- Nordion Inc
- Qiagen GmbH
- F.Hoffmann-La Roche Ltd.
- Biomerieux
- Cepheid

第7章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI992

Hospital-Acquired Disease Testing Market is estimated to be valued at USD 18.6 Bn in 2026 and is expected to reach USD 49.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 18.6 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	15.50%	2033 Value Projection:	USD 49.4 Bn

Hospital-acquired infections are acquired by the patient under medical care. The most common types of hospital-acquired infections are urinary tract infections, bloodstream infections, Methicillin-resistant Staphylococcus aureus (MRSA), pneumococcal infections, and gastrointestinal illnesses. An increasing rate of morbidity related to hospital-acquired infections worldwide is a major factor driving the growth of the hospital-acquired disease testing market. Devices such as catheters and ventilators that are used in modern care facilities are also among the primary causes of these infections.

Market Dynamics

Key players in the market are focused on adoption of expansion strategies such as mergers and acquisitions, collaborations, and partnerships in order to expand their product portfolio and global presence in the hospital-acquired disease testing market. For instance, in April 2019, Meridian Bioscience, Inc. entered an agreement to acquire GenePOC Inc., a Canada based provider of molecular diagnostic instruments and assays. Through this acquisition, Meridian Bioscience will include state-of-the art revogene molecular diagnostics platform of GenePOC Inc. in its diagnostics portfolio.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hospital-acquired disease testing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Luminex Corporation, Diatherix laboratories, Life technologies, Cantel Medical Corporation, Meridian Biosciences Inc, Nordion Inc, Qiagen GmbH, F.Hoffmann-La Roche Ltd., Biomerieux, and Cepheid.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, product Type up-gradation, market expansion, and marketing tactics
The global hospital-acquired disease testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hospital-acquired disease testing market

Market Segmentation

By Test Type
- Urinary Tract Infection
- Surgical Site Infection
- Pneumonia Stents
- Blood Stream Infection
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Others
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players
- Luminex Corporation
- Diatherix Laboratories
- Life Technologies
- Cantel Medical Corporation
- Meridian Biosciences Inc
- Nordion Inc
- Qiagen GmbH
- Hoffmann-La Roche Ltd.
- Biomerieux
- Cepheid

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Hospital-Acquired Disease Testing Market, By Test Type, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
Urinary Tract Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Surgical Site Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Pneumonia Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Blood Stream Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Methicillin-resistant Staphylococcus Aureus (MRSA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

5. Global Hospital-Acquired Disease Testing Market, By Region, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa